Log In
Print
BCIQ
Print
Print this Print this
 

UCB4940

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionUndisclosed antibody-based product
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat immunological diseases
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today